MedTrace Logo

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

NCT05226767 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-02-07

No results posted yet for this study

Summary

This study is designed to evaluate the safety and efficacy of NLC-V in patients diagnosed with COVID-19.

Conditions

Interventions

DIETARY_SUPPLEMENT

NLC-V

NLC-V

Sponsors & Collaborators

  • Todos Medical, Ltd.

    lead INDUSTRY

Principal Investigators

  • Dorit Arad, PhD · Todos Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-30
Primary Completion
2021-11-02
Completion
2022-01-20

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05226767 on ClinicalTrials.gov